Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Understanding Prescribing Differences Between Urologists and Medical Oncologists in the Management of Advanced Prostate Cancer.

Urology practice·2023

Same author

Reply by Authors.

Urology practice·2023

Same author

A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent.

Clinical cancer research : an official journal of the American Association for Cancer Research·2022

Same author

Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer.

Clinical genitourinary cancer·2020

Same author

Stromal-epithelial interactions in prostate cancer: Overexpression of PAGE4 in stromal cells inhibits the invasive ability of epithelial cells.

Journal of cellular biochemistry·2020

Same author

How do we define "castration" in men on androgen deprivation therapy?

Asian journal of andrology·2020

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Biomarkers for prostate cancer.

Eddy S Leman¹, Robert H Getzenberg

¹The Brady Urological Institute and the Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.

Journal of Cellular Biochemistry

|June 10, 2009

Summary

Prostate-specific antigen (PSA) revolutionized prostate cancer detection but lacks specificity. New molecular biomarkers are needed to accurately identify prostate cancer and improve early detection strategies.

Area of Science:

Oncology
Biomarker Discovery
Urology

Background:

Prostate-specific antigen (PSA) blood tests have significantly advanced prostate cancer detection.
Limitations of PSA include its lack of specificity, leading to elevated levels in non-cancerous prostate conditions.
There is a critical need for more specific biomarkers to accurately diagnose prostate cancer.

Purpose of the Study:

To review the discovery of PSA as a pioneering blood-based biomarker for prostate cancer.
To explore other molecular biomarkers and their potential for improved prostate cancer detection.
To discuss the ongoing search for more accurate and clinically useful prostate cancer biomarkers.

Main Methods:

Review of the literature on prostate cancer biomarkers.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Related Experiment Videos

Last Updated: Jun 22, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Analysis of the discovery and application of PSA.

Investigation of emerging molecular markers including PSA isoforms and nucleic acids.

Main Results:

PSA remains the primary blood test for prostate cancer detection.
Various other molecular markers are under investigation for enhanced specificity.
The development of novel biomarkers aims to differentiate prostate cancer from other prostatic diseases.

Conclusions:

While PSA was a breakthrough, its limitations necessitate the development of more specific biomarkers.
Emerging molecular markers show promise for improving the accuracy of prostate cancer diagnosis.
Continued research into novel biomarkers is essential for advancing prostate cancer screening and detection.